Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Other Accumulated Expenses (2018 - 2025)

Inventiva (IVA) posted quarterly Other Accumulated Expenses of $17.2 billion for Q2 2025, up 273225.25% year-over-year from N/an in Q2 2024, and up 86.86% quarter-over-quarter from $9.2 billion in Q4 2024.

Analysis

Inventiva (IVA) Other Accumulated Expenses (2018 - 2025) Analysis & Trends

Inventiva's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $17.2 billion for Q2 2025.

  • In Q2 2025, Other Accumulated Expenses rose 273225.25% year-over-year to $17.2 billion; the TTM figure through Jun 2025 stood at $17.2 billion (up 273225.25% YoY), while the FY2024 annual figure was $9.2 billion, up 119108.59% from the prior year.
  • Other Accumulated Expenses for Q2 2025 stood at $17.2 billion, up from $9.2 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $17.2 billion in Q2 2025, with the low at $5.4 million in Q2 2023.
  • The 5-year median for Other Accumulated Expenses is $8.2 million (2023), against an average of $3.9 billion.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses slumped 99.93% in 2022, then surged 273225.25% in 2025.
  • Inventiva's Other Accumulated Expenses stood at $7.8 billion in 2021, then plunged by 99.93% to $5.6 million in 2022, then soared by 37.76% to $7.7 million in 2023, then surged by 119108.59% to $9.2 billion in 2024, then jumped by 86.86% to $17.2 billion in 2025.
  • Business Quant data shows IVA's Other Accumulated Expenses at $17.2 billion in Q2 2025, $9.2 billion in Q4 2024, and $6.3 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.93 Mn
Jun 30, 2025 17.17 Mn
Dec 31, 2024 9.19 Mn
Jun 30, 2024 6.25 Mn
Dec 31, 2023 7.71 Mn
Jun 30, 2023 5.42 Mn
Dec 31, 2022 5.60 Mn
Jun 30, 2022 5.01 Mn
Dec 31, 2021 7.77 Mn
Jun 30, 2021 5.43 Mn
Mar 31, 2021 8.71 Mn
Dec 31, 2020 8.15 Mn
Jun 30, 2020 5.88 Mn
Mar 31, 2020 6,623.63
Dec 31, 2019 5.53 Mn
Dec 31, 2018 5.56 Mn